| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | +57.0% |
| SG&A Expense | $3.1M | -55.4% |
| Operating Income | -$6.2M | +26.2% |
| Net Income | -$6.2M | +26.2% |
| EPS (Basic) | -$0.24 | +27.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $220K | -93.9% |
| Current Assets | $402K | -89.2% |
| Total Assets | $2.2M | -53.5% |
| Current Liabilities | $369K | +85.4% |
| Total Liabilities | $443K | +122.6% |
| Stockholders' Equity | $1.7M | -61.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | -121.1% |
| Capital Expenditures | $18K | +26.1% |
| Investing Cash Flow | -$365K | -163.5% |
| Financing Cash Flow | $350K | -92.5% |
| Free Cash Flow | -$3.4M | -120.2% |